Table 1.
Baseline characteristics
| ParkFit (n=299) | Controls (n=287) | |
|---|---|---|
| Demographics and clinical characteristics | ||
| Mean (SD) age (years) | 65.1 (7.9) | 65.9 (7.2) |
| Male sex | 194 (65) | 188 (65) |
| Mean (SD) body mass index | 27.4 (4.5) | 27.6 (4.0) |
| Mean (SD) disease duration (years) | 5.0 (4.5) | 5.5 (4.6) |
| Mean (SD) mini-mental state examination score | 28.1 (1.7) | 28.1 (1.7) |
| Modified Hoehn and Yahr stage (No (%)): | ||
| 1 | 7 (2) | 4 (1) |
| 1.5 | 7 (2) | 10 (3) |
| 2 | 221 (74) | 223 (78) |
| 2.5 | 48 (16) | 36 (13) |
| 3 | 16 (5) | 14 (5) |
| Mean (SD) unified Parkinson’s disease rating scale, part III | 33.1 (11.3) | 32.3 (9.5) |
| Mean (SD) daily levodopa equivalent dose (mg) | 458 (362) | 499 (414) |
| Level of physical activity | ||
| Median (interquartile range) LAPAQ (hours per week) | 12.8 (8.3-20.3) | 13.8 (8.3-23.9) |
LAPAQ = LASA physical activity questionnaire.